CEACAM5 and breast cancer: Currently, accurate evaluation of tumor response to NAC is limited, and measurement of conventional BC markers like ER, PR, P-53, carcinoembryonic antigen (CEA), cancer antigen 15-3 (CA15-3) & HER-2/neu has shown limited predictive value in the NAC setting [9,10].